Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas

التفاصيل البيبلوغرافية
العنوان: Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas
المساهمون: Walter Hanel, Principal Investigator
المصدر: A Phase I Study of Romidepsin in Combination With Parsaclisib in Relapsed and Refractory T-Cell Lymphomas
قاعدة البيانات: ClinicalTrials.gov